Magrolimab

Modify Date: 2024-01-11 15:23:51

Magrolimab Structure
Magrolimab structure
Common Name Magrolimab
CAS Number 2169232-81-7 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Magrolimab


Magrolimab (Hu5F9-G4) is a first-in-class humanized anti-CD47 IgG4 antibody with an anti-tumor activity[1].

 Names

Name Magrolimab

 Magrolimab Biological Activity

Description Magrolimab (Hu5F9-G4) is a first-in-class humanized anti-CD47 IgG4 antibody with an anti-tumor activity[1].
Related Catalog
References

[1]. Caner Saygin, et al. Current and emerging strategies for management of myelodysplastic syndromes. Blood Rev. 2021 Jul;48:100791.

 Chemical & Physical Properties

No Any Chemical & Physical Properties